“…[62] In vitro experiments revealed that TiO 2 -Ce6-CpG showed an efficient internalization into the cells (Figure 7c). After various experimental analysis, it was found that CD11c and CD86 as the representative markers of DCs maturation were up-regulated, Enhanced SDT and immune response stimulation [62] Mn-MOF Mn-MOF 4T1 Cyclooxygenase activity rise and GSH content drop [88] sPD-1/Ce6-NBs Ce6, NBs HCC Induced UTND, enhanced SDT and immune response [89] RBC-mTNPs@AQ4N mTNPs, AQ4N, RBC MCF-7 Immune escape, hypoxia activation chemotherapy [63] THPP-Oxa(IV)-PEG THPP, Oxa(IV)SA 2 , PEG 5k -COOH CT26 Immunogenic nanodrug and radioisotope imaging [90] PIH-NO HSA-NO, FDC, IR780 4T1 Mitochondrial damage, drug accumulation, and M2 macrophage polarization into M1 phenotypes [91] LiP-PFH DPPC, DSPC, DSPE-PEG2000 4T1 Enhanced anti-tumor immunity [92] OI_NPs OXP, ICG, PFP ID8 Improved optical and ultrasonic imaging [93] FA-MnPs MNP, FA TNBC M2 macrophages polarized to M1 phenotype, ICD response to activate NK, DC maturation [94] RSL3@O 2 -ICG NBS NBS, ICG, RSL3 HCC Ferroptosis [87] SnNSs@PEG 2D SnNS, PEG H1299 Excellent photothermal efficiency [64] MPN-PALF LOX, ATO, Ce6 4T1 Relieving acidic TME [95] MG@PNPs PMnC, Gox 4T1 MR/PA dual-mode imaging and tumor starvation treatment [96] 𝛼-Fe 2 O 3 @Pt 𝛼-Fe 2 O 3 , Pt 4T1 Inhibiting electron-hole pairs recombination for ROS production [97] P/M@CasMTH1 MOF, CRISPR-Cas9, MTH1 A549 Controlled release and enhanced SDT [86] MitoCAT-g CAT-g, CA, TPP HCC GSH exhaustion [84] Wettability of nanoparticles MSN, PSS Thrombus Enhanced SDT [59] FA-N-GQds FA, N-GQD, pyridine N, pyrrole N MDA-MB-231 High tumor labeling rate [61] ZIF-8 NCS ZIF-8, MOF 4T1 Acidic TME modulation [80] IRO@FANP PLGA, PEG, FA ID8 Enhanced SDT [98] IR820@NCP IR820, FTS HCC Tumor aggregation and fluorescence imaging [99] Pd/H-TiO 2 NSS Pd, NSS C6 Enhanced CDT and SDT [100] indicating that nanosonosensitizer TiO 2 -Ce6-CpG could significantly promote DCs maturation in vitro. In the in vivo experiment of female C57BL/6 mice inoculated with Hepa1-6, it was found that the treatment with such composite sonosensitizers (TiO 2 -Ce6-CpG) combination with PD-L1 inhibitor could not only effectively inhibit the primary tumor but also significantly delay the growth of distant tumors (Figure…”